Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01241305 · ClinicalTrials.gov registry record

One-Time DNA Study for Vasculitis

A clinical trial of Giant Cell Arteritis and Microscopic Polyangiitis, sponsored by University of Pennsylvania.

Recruiting
Registry status
1,000
Enrollment target
14
Study locations

NCT01241305 is a study of Giant Cell Arteritis and Microscopic Polyangiitis that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 1,000 participants, above the 907-participant average among 7 other Giant Cell Arteritis trials with a reported enrollment target (10% higher). The trial reports 14 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01241305, a study of Giant Cell Arteritis and Microscopic Polyangiitis, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
1,000 participants
Enrollment target
14
Study locations

Study Summary

The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.

Conditions Studied

Giant Cell Arteritis Microscopic Polyangiitis Takayasu's Arteritis Polyarteritis Nodosa Granulomatosis With Polyangiitis (Wegener's) Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)

Study Locations (14)

California

  • Cedars-Sinai Medical Center - Los Angeles
  • University of California, San Francisco - San Francisco

Pennsylvania

  • University of Pennsylvania - Philadelphia
  • University of Pittsburgh - Pittsburgh

Ontario

  • St. Joseph's Healthcare - Hamilton
  • Mount Sinai Hospital - Toronto

Illinois

  • Northwestern University - Chicago

Kansas

  • University of Kansas Medical Center - Kansas City

Michigan

  • University of Michigan - Ann Arbor

Minnesota

  • Mayo Clinic - Rochester

New York

  • Hospital for Special Surgery - New York

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2010-10
Est. Completion 2028-08

Sponsor

University of Pennsylvania

1,423 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01241305

The ClinicalTrials.gov registry entry for NCT01241305 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 907-participant average among 7 other Giant Cell Arteritis trials with a reported enrollment target (10% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Giant Cell Arteritis appearing as the primary indexed condition, and to 0 interventions.

NCT01241305 reports 14 study locations spanning 11 distinct geographic areas - top geographies include California, Pennsylvania, Ontario.

Frequently Asked Questions

What is clinical trial NCT01241305 about?

NCT01241305 is a clinical study titled "One-Time DNA Study for Vasculitis". The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas fo...

What is the current status of trial NCT01241305?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2010-10. Estimated completion is 2028-08.

What conditions does trial NCT01241305 study?

This clinical trial studies the following conditions: Giant Cell Arteritis, Microscopic Polyangiitis, Takayasu's Arteritis, Polyarteritis Nodosa, Granulomatosis With Polyangiitis (Wegener's).

Who is sponsoring clinical trial NCT01241305?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01241305 being conducted?

This trial has 14 study locations across California, Illinois, Kansas, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Giant Cell Arteritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Giant Cell Arteritis

All registered trials for this condition

Microscopic Polyangiitis

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.